Embedded Files
The UK MND Clinical Studies Group is a national network of experienced MND clinical researchers located across the whole of the UK, which provides the geographical coverage to conduct large multi-centre MND trials that are able to deliver on time and to target.
Support for the life science industry
Support for the life science industry
The UK MND Clinical Studies Group coordinates the national network of MND clinical trial sites. It comprises 51 members across 28 centres, PPI representatives and national charity partners. The group provides strategic oversight of the UK portfolio of MND clinical trials and healthcare research studies.
Acting as a single point of contact for sponsors, the group supports:
Direct engagement with investigators
Identification of UK sites with appropriate capacity and capability
Feasibility input on study design within the context of UK clinical practice
Centralised site identification and completion of feasibility assessments
Access to established and highly engaged MND PPI panels, providing feedback on research proposals and participant-facing materials
A costing guidance tool for commercial MND trials, supporting sponsors and lead sites through the NCVR process
For additional information or to discuss how we can support your research, please contact info.ukmndcsg@gmail.com
Clinical Trial Costing Guidance for MND_v1_18May2023.pdfGuidance Tool for costing clinical trials
Guidance Tool for costing clinical trials
The group has created a costing guidance tool, aimed at helping industry and trial sites determine fair and uniform costing throughout all clinical trial sites in the UK.
Download the guidance document here: Clinical Trial Costing Guidance for MND
The intention is to encourage sponsors to utilise this guidance when they first generate a study budget in the national costing tool (the NIHR interactive costing tool, or iCT), and then support the lead site when they review the budget during the national contract value review. The goal is to reduce the need for protracted budget negotiations at each site, therefore reducing workload and speeding up set-up; and to have a fairer and more transparent costing process so that there is less budget variability between sites.
For additional information or to discuss how the MND CSG can help industry and sites with trial costings please contact info.ukmndcsg@gmail.com
Ways of working
Ways of working
The group holds information in strict confidence and members are used to dealing with commercially sensitive material; industrial parties can be reassured that documents and discussions remain confidential. The Group coordinator is experienced with setting up complex multi-centre trials and can guide companies through the ethical, regulatory and research governance processes in the UK.
Key stakeholders
Key stakeholders
The group works closely with our partners, including:
UK Clinical Research Network (CRN) – Neurodegeneration speciality
Allied healthcare professionals working within MND
Patient advisory groups and representatives of people affected by MND
The wider MND community
Commercial partners
Page updated
Report abuse